InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Louria Hayon Igal. Officer active across 1 company, notably Raphael Pharmaceutical Inc.. Aggregated, 2 reports have been published. History available since 29 August 2023. The latest transaction was disclosed on 20 November 2025 (X). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条